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Dietary phytochemical intake from foods and health outcomes: A
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Abstract
Introduction: Dietary phytochemicals are found in plant-based foods such as fruits, vegetables and grains and
may be categorised in a nested hierarchical manner with many hundred individual phytochemicals identified
to date. To associate phytochemical intakes with positive health outcomes, a fundamental step is to accurately
estimate the dietary phytochemical intake from foods reported. The purpose of this systematic review
protocol is to describe the process to be undertaken to summarise the evidence for food-based dietary
phytochemical intakes and health outcomes for adults.
Methods and analysis: The review will be undertaken following the PRISMA guidelines and the Cochrane
Handbook for Systematic Reviews of Interventions using the Review Manager software. Phytochemical
subclasses (phenolic acids, flavanols, etc) will be used to search for relevant studies using the Web of Science
and Scopus scientific databases. The retrieved studies will be screened based on inclusion of natural whole
food items and health outcomes. Phytochemical studies related to cardiovascular disease, cancer, overweight,
glucose tolerance, digestive, reproductive, macular and bone health and mental disorders, fatigue and
immunity will be examined based on prior scoping. The evidence will be aggregated by the food types and
health outcomes. Comparison of differences in the outcomes for randomised controlled trials and
observational studies will be undertaken. The strength of the review lies in its focus on whole food items and
health conditions rather than one type of phytochemical related to one single health condition. Subgroup and
sensitivity analyses will be conducted where an adequate number of publications are found per phytochemical
subclass.
Dissemination: By comparing the outcomes from experimental and observational studies, the review will
determine whether the overall conclusions related to the phytochemical subclasses are the same between
study types for the identified health conditions. This is useful to public health policymakers and health
professionals alike.
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ABSTRACT
Introduction: Dietary phytochemicals are found in
plant-based foods such as fruits, vegetables and grains
and may be categorised in a nested hierarchical
manner with many hundred individual phytochemicals
identified to date. To associate phytochemical intakes
with positive health outcomes, a fundamental step is to
accurately estimate the dietary phytochemical intake
from foods reported. The purpose of this systematic
review protocol is to describe the process to be
undertaken to summarise the evidence for food-based
dietary phytochemical intakes and health outcomes for
adults.
Methods and analysis: The review will be
undertaken following the PRISMA guidelines and the
Cochrane Handbook for Systematic Reviews of
Interventions using the Review Manager software.
Phytochemical subclasses (phenolic acids, flavanols,
etc) will be used to search for relevant studies using
the Web of Science and Scopus scientific databases.
The retrieved studies will be screened based on
inclusion of natural whole food items and health
outcomes. Phytochemical studies related to
cardiovascular disease, cancer, overweight, glucose
tolerance, digestive, reproductive, macular and bone
health and mental disorders, fatigue and immunity
will be examined based on prior scoping. The
evidence will be aggregated by the food types and
health outcomes. Comparison of differences in the
outcomes for randomised controlled trials and
observational studies will be undertaken.
The strength of the review lies in its focus on
whole food items and health conditions rather than
one type of phytochemical related to one single
health condition. Subgroup and sensitivity
analyses will be conducted where an adequate
number of publications are found per phytochemical
subclass.
Dissemination: By comparing the outcomes from
experimental and observational studies, the review
will determine whether the overall conclusions
related to the phytochemical subclasses are the
same between study types for the identified health
conditions. This is useful to public health
policymakers and health professionals alike.
Trial registration number: #CRD42014015610.
BACKGROUND
Dietary phytochemicals are commonly found
in plant-based foods such as fruits, vegeta-
bles, grains and tea.1 Consumption of total
phytochemical intake is consistently linked
with protection from chronic diseases,2
including cardiovascular disease,3–5 cancer6 7
and neurodegenerative diseases.8 In order to
associate phytochemical intakes from food
with positive health outcomes, a fundamental
step is to accurately estimate dietary phyto-
chemical intakes. Despite the first estima-
tions of phytochemical intake from food at a
population level being reported more than a
decade ago, the methods currently employed
have evident flaws.9 Traditional methods of
dietary assessment require a recall or docu-
mentation of food intakes from a given time
period in either a prospective or retrospect-
ive manner.10 To determine the nutrient
composition of individual or group intakes,
this dietary intake data needs to be con-
verted to an estimated consumption of the
‘nutrient’ of interest. This can be performed
by applying a phytochemical food compos-
ition database (FCDB) to the dietary intake
data.11
Aside from the limitations associated with
each dietary assessment method,10 there are
also several well-documented problems asso-
ciated with using FCBDs to assign phyto-
chemical content (including type and
concentration) to selected foods, resulting in
large variations in estimates of intake.9 12
First, estimation of dietary phytochemical
intake is only as comprehensive as the FCDB
used. If, for example, a database does not
have an extensive list of food items and the
phytochemical content of a food in an indivi-
dual’s diet cannot be assigned or matched to
its closest equivalent,13 then an individual’s
intake will be underestimated. This is particu-
larly challenging when analysing food intake
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data from a country that does not have a phytochemical
FCDB specific to the food supply, resulting in significant
sources of phytochemicals not being captured.14 The
primary FCDBs used by studies (USDA, Phenol Explorer
and Euro FIR-eBASIS) provide extensive information on
the individual phytochemicals in foods, with additional
details provided for the variability of phytochemical con-
tents in foods, as well as the values associated with pro-
cessing. It is interesting to note that using different
FCDB may substantially influence the estimation of
phytochemical intake in a study, as highlighted by a
recent comparison between estimates of dietary phyto-
chemical intake produced by the US Department of
Agriculture (USDA) and Phenol Explorer databases.15
However, this is not a well-researched concept and needs
further verification. Second, the phytochemical content
of specific foods is highly variable and influenced by a
foods growth, harvest and processing conditions.
Disregarding the processes by which foods are produced
and the impact on the phytochemical levels may lead to
an overestimation of the phytochemical intakes. A phyto-
chemical FCBD is unable to account for all of the vari-
ability and can only provide an estimate for each food
consumed. Finally, estimating dietary phytochemical
intakes through dietary assessment is unable to account
for the high intraindividual variation associated with
phytochemical metabolism and absorption, which is
influenced by factors other than intake, such as bioavail-
ability and genetic factors.
Rationale
Description of the problem or issue
Dietary phytochemicals are bioactive compounds that
are commonly found in plant-based foods such as fruits,
vegetables, grains and tea. Many studies, including
animal models, population observations and clinical
trials, have been conducted to investigate the protective
effects of dietary phytochemical intakes from food.16–21
Phytochemicals may be categorised in a nested hier-
archical manner of classes and subclasses. For example,
total polyphenols comprises flavonoids, phenolic acids,
lignans and other polyphenol groups.22 Flavonoids can
be further divided into anthocyanins, flavan-3-ols, flava-
nones, flavones, flavonols, isoflavones and proanthocya-
nidins subclasses.22 Current published reviews tend to
focus only on the relationship between a single subclass
of phytochemical and one health condition regardless
of the source of phytochemical, that is, compound
extraction and synthesis, or from whole food source.23–28
Although it is valuable to isolate the specific phytochem-
ical to reveal their mechanism of action, it may be prob-
lematic in reflecting dietary consumption. People eat
food and therefore dietary phytochemical research
should consider the whole food matrix.
Many whole foods, such as apples, blueberries, broc-
coli, cherries, soy beans and walnuts, are naturally rich
in phytochemicals, but are also high in micronutrients
and fibres.29 30 As phytochemical compounds do not
exist in isolation in these foods, the whole food matrix
may play a role in the protective effects of phytochem-
icals. It has been suggested that phytochemicals con-
sumed as a part of their natural food matrix may be
more bioactive than a high dose of isolated phytochem-
icals provided by dietary supplements.31 This may be
attributed to phytochemicals working synergistically with
other phytochemicals that are inherently present in the
food.32 Furthermore, their bioactivity may also be attrib-
utable to the interactions between the phytochemicals
and other nutrients (eg, vitamin C)31 or other constitu-
ents or contaminants in the food. For example, polyphe-
nols found in whole grain foods have been considered
to contribute to the health benefits observed.33
However, the health benefits of whole grain consump-
tion related to polyphenols may also be linked to the
cereal fibre or other components that naturally occurs
in the grain.34 Such patterns cannot be determined by
isolating the phytochemicals. Reviews have been con-
ducted previously for specific phytochemical-rich whole
food items such as strawberries;35 however, the focus
remained on single phytochemical subclasses, namely,
strawberry polyphenols. Such reviews should consider
the synergistic interactions occurring within the
phytochemical-rich whole food matrix. Although other
nutrients, such as micronutrients and fibre, naturally
occur in phytochemical-rich whole foods, the phyto-
chemical content of a given whole food can be esti-
mated using dietary assessment tool and phytochemical
FCDBs, which can be further compared across the
studies. Thus, grouping and analysing phytochemical
content of phytochemical-rich whole foods can still be
achieved, but may also need to take into account the
foods synergistic effect and human consumption habits.
Examining phytochemical-rich whole foods rather than
specific classes of phytochemicals may reflect the dietary
consumption characteristics that are in turn translatable
to dietary advice.
Translation to dietary advice also requires consider-
ation of the health conditions being addressed. Common
risk factors and biomarkers have been found for different
diseases, particularly lifestyle-related chronic diseases
such as cardiovascular disease, type 2 diabetes mellitus
and various forms of cancer. Endothelial dysfunction bio-
markers including E-selectin, intercellular adhesion mol-
ecule 1 and vascular cell adhesion molecule 1 are
common risk factors related to cardiovascular diseases
and type 2 diabetes mellitus,36 37 while inflammatory bio-
markers such as C-reactive protein are common to the
development of type 2 diabetes mellitus and cancer.38 39
Therefore, this review will consider a range of whole food
items and disease states, which to date have not been
addressed in reviews of this nature.
Another limitation hindering the interpretation of
phytochemical studies are the differences between
observational and experimental research outcomes that
demonstrate associations of dietary phytochemical
intakes with specific health outcomes.5 40 Population-
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based observational studies often provide evidence of
associations between diet and disease, while experimen-
tal studies, particularly randomised controlled trials, are
designed to reduce bias and confounding to reveal rela-
tionships via hypothesis testing of outcomes from these
observational studies.41 A comparison of outcomes
related to phytochemical intakes in observational and
experimental research is imperative to interpret current
findings across the literature and to provide recommen-
dations for future research.
Description of the methods being investigated
Figure 1 provides an overview of the proposed approach
to the systematic literature review to be conducted. There
are currently numerous methods used to measure dietary
phytochemical intakes in different settings. This system-
atic review will consider studies that use any form of
dietary assessment translated to ‘nutrient’ data to estimate
consumption of dietary phytochemicals or the intake of
specific phytochemical-rich food items. Although it is
recognised that biomarkers of intake may be used as a
means to measure intake, studies using biomarkers of
intake will not be included in the review. Validation and
methodological studies for dietary assessment tools will
also be excluded as the outcomes are unlikely to relate to
the health outcomes, the focus of the review.
How these methods might work
The proposed review will consider the various subclasses
of the phytochemical class overall. Although the evi-
dence aggregation will be based on individual food
items, it will specifically focus on the whole food matrix
and its nutrient synergies. For example, foods high in
whole grains are also high in dietary fibre and polyphe-
nols, a class of phytochemical. For this review, the inte-
rest is related to the polyphenols content of the
wholegrain foods rather than the dietary fibre.
Therefore, the specific phytochemical compounds will
be used to search for the relevant studies to capture the
various subclasses of the phytochemical class overall. As
common risk factors and health biomarkers are shared
across different health conditions, as demonstrated
above, the health outcomes will not be limited during
the key word searches. The health outcomes-related
phytochemical studies will be identified during the study
abstract screening phase. In the evidence synthesis
phase, the phytochemical content of phytochemical-rich
whole foods will be extracted and summarised based on
the reported values and units. The identified values will
be used as a benchmark to compare across studies.
Finally, aggregation of evidence based on the individual
foods rather than the phytochemical classes is more
likely to reflect eating behaviours, as different phyto-
chemical compounds may have positive protective
effects on the same biomarker or health outcome. For
example, brassica vegetables such as broccoli, Brussels
sprouts and cabbage are naturally low in flavonoid com-
pounds though are high in glucosinolates.42 Flavonoids
and glucosinolates are phytochemicals and have demon-
strated protective effects related to cancer risk in human
population studies.43 44 Thus, the proposed approach to
the systematic literature review will provide novel insight
into health outcomes associated with phytochemical-rich
food consumption, while considering eating behaviours.
Within the studies, the methods used to determine the
phytochemical content of the food items will be consid-
ered to determine if there is consistency within the
health outcome categories of interest.
Why it is important to do this review
As stated earlier, current reviews with phytochemicals
focus on one health condition and/or one specific sub-
class of phytochemical, for example, anthocyanins.
Further to this, other reviews focus on either experimen-
tal or observational study designs, but do not attempt to
compare both.45–47 Although the workload substantially
increases when considering all studies, this will allow the
current review to determine whether the conclusions
being made by the differing study types are consistent.
In addition, focussing on phytochemicals from whole
food sources rather than from a process of compound
extraction and/or synthesis again relates to eating beha-
viours. By considering a range of phytochemical sub-
classes and health outcomes, this review will relate
outcomes to the whole food matrix of different foods
rather than focusing on a single specific food compo-
nents which to date have also not been addressed.
Objectives
The purpose of this review is to summarise and synthe-
sise the evidence about dietary phytochemical intakes
from whole foods related to health outcomes in rando-
mised and non-randomised food-based trials, prospective
and retrospective cohort, case–control, cross-sectional
studies that aim to measure or estimate dietary phyto-
chemical intakes in adults. The specific question that
the review following this protocol will address utilises a
PICO format and is proposed as: In food-based studies
for phytochemical intake, what is the impact on chronic
disease outcomes for adults?
Figure 1 Overview of the proposed approach to the
systematic literature review to be conducted.
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The following questions will also be used guide the lit-
erature search:
▸ What is the primary health outcome reported from
the study and how does this relate to chronic disease?
▸ Does the study focus on whole foods, not supplements?
▸ Are the phytochemical outcomes a primary focus to
the ‘nutrients’ reported for the study?
It is hypothesised that the review will show an association
between the number of studies related to a phytochemical
subclass and consistency of the outcomes reported.
METHODS
This review was registered with the International
Prospective Register of Systematic Reviews (PROSPERO)
under the registration number #CRD42014015610.
The structure of this review protocol follows the
Preferred Reporting Items for Systematic Review and
Meta-Analyses (PRISMA) guidelines and the recommen-
dations of the Cochrane Handbook for Systematic
Reviews of Interventions using Review Manager
(RevMan) Computer program, V.5.3.5, Copenhagen:
The Nordic Cochrane Centre, The Cochrane
Collaboration, 2014. This protocol was developed in line
with the PRISMA-P 2015 checklist.48 49
Eligibility criteria for considering studies
Types of studies
This review will include randomised, non-randomised
food-based trials and crossover food-based trials, and
analytical epidemiological study designs including pro-
spective and retrospective cohort, case–control and
cross-sectional studies.
Types of participants
No restrictions will be set for the age or gender of parti-
cipants, though participants must be diagnosed with a
chronic disease. These chronic diseases will be used for
subgroup statistical analyses.
Setting and time frame
Studies will be restricted to those published from
January 2004 to March 2016 to ensure the literature is
relevant. Studies published before 2004 are not included
due to a focus on mechanistic studies as identified
during the scoping phase.
Types of data
The main data will be the dietary phytochemical intakes
from foods related to health outcomes from different study
designs. The details of study characteristics and consump-
tion of phytochemicals will be examined. The trends and
patterns of dietary phytochemical intake from foods and
health outcomes in different study designs will be explored.
Types of methods
Studies reporting data for whole food-based phytochem-
ical outcomes in relation to a health condition will be
included. Studies that do not measure whole foods or
whole of diet-based phytochemical intakes (ie, encapsu-
lated phytochemicals extract, extract from herbal sources
and purified or modified version of phytochemicals) and
other mechanistic studies (ie, bioavailability or mechanis-
tic feeding studies) will be excluded. The phytochemical-
containing foods must be identified as naturally contain-
ing phytochemicals (with a reference to a study character-
ising the phytochemical composition of the food, or
reference to a comprehensive FCDB). The identified
phytochemical-rich food must also be commercially avail-
able or publicly accessible by a general population.
Information sources
The search aims to find published and unpublished
studies through electronic scientific databases, the Internet
and reference lists of included studies. Key terms have
been developed (see online supplementary appendix 1).
The initial phase will consist of searches of the following
databases as the two largest health-related databases:
▸ Web of Science
▸ Scopus
Only studies published in the English language will be
considered for inclusion due to a lack of translation
resources. Ongoing clinical trials will be searched for
using the Australian Government National Health and
Medical Research Council and Department of Industry,
Innovation and Science Clinical trials registries (https://
www.australianclinicaltrials.gov.au/clinical-trial-registries)
using the phytochemical subclasses listed in online
supplementary appendix 1.
Search strategy
An example search strategy as applied to the Scopus scien-
tific database is shown below including limits to the year
of publication, document type and a focus on human
studies to exclude many of the mechanistic studies.
(TITLE-ABS-KEY (lignans OR ‘flavan-3-ol*’ OR terpene*
OR carotenoid* OR limonoid* OR phytosterol* OR thiol*
OR glucosinolate* OR indole* OR isoprenoid* OR ‘Lipoic
acid’OR ubiquinone OR ‘Phenolic acid’OR flavonoid* OR
flavanol* OR tannin* OR stilbene* OR lignans OR isofla-
vone* OR anthocyanin* OR flavanone* OR flavonol* OR
flavone* OR allicin OR capsaicin OR catechin OR ‘Ellagic
acid’ OR genistein OR lycopene OR saponin* OR zeax-
anthin OR polyphenol*) AND TITLE-ABS-KEY
(((randomi?ed W/6 control) AND (trial OR study)) OR
(cohort W/6 stud*) OR (longitudinal W/6 stud*) OR
‘panel stud*’) AND NOT TITLE-ABS-KEY (rat OR mice OR
cell)) AND PUBYEAR > 2004 AND (LIMIT-TO (DOCTYPE,
‘ar’) OR LIMIT-TO (DOCTYPE, ‘re’) OR LIMIT-TO
(DOCTYPE, ‘ip’)) AND (LIMIT-TO (EXACTKEYWORD,
‘Human’) OR LIMIT-TO (EXACTKEYWORD, ‘Humans’))
Study records
Selection process
The review will be structured and reported according to
PRISMA. One review author (YCP) will conduct the litera-
ture search in the specified scientific databases. Results of
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the search will be collated in the reference management
software Endnote (version X7.5, Thomson Reuters, 2016).
Duplicate publications will be excluded. Two review authors
(KK and VXG) will independently screen publications
using the criteria (table 1) for inclusion. Resolution of any
disagreements will occur through discussion and required
consultation with a third reviewer (YCP) for consensus.
The observational studies will be considered separately
to other studies to determine any differences in
methods reported. Articles identified by database
searches will be assessed for relevance to the review
based on the title and abstract (table 1). For those
meeting the inclusion criteria, the full-text publications
will be retrieved and assessed for relevance to the review
criteria. A PRISMA flow diagram of the search strategy
and selection process will be developed.
Data extraction and data management
Eligibility for inclusion will be confirmed by an independ-
ent researcher (SM). Data extracted from the studies will
be entered into RevMan software V.5.3.5 by the same
researcher. Data accuracy will be checked by double data
entry having one review author (VXG) entering data into
a separate file and comparing the results for a subset of
studies. Consensus will be sought by consultation with a
third researcher (YCP). When the information regarding
any of the above is unclear, YCP will attempt to contact
authors of the original publication to provide further
details. The studies will be grouped, described and evalu-
ated in accordance with their methodological similarities.
Studies will also be separated into their experimental or
observational design. Studies will be further grouped by
their health condition and phytochemical subclass.
Data items
Data collection process
To ensure internal bias is minimised, the review will be
undertaken by more than one researcher with quality
assessed between the methods of data extraction.
Outcome measures and prioritisation
Primary outcomes
The primary outcome is the summary of dietary phyto-
chemical intakes from foods by subclass and health out-
comes from different study designs. The phytochemical
subclasses were determined based on the classification
system outlined in the Handbook of plant food
phytochemicals.22
This review will consider studies that investigate dietary
phytochemical intake from whole foods by addressing at
least one of the following health outcomes:
Health outcomes:
▸ Cardiovascular disease
– Cholesterol
– Heart disease
– Hypertension
– Blood pressure
▸ Cancer
– Oxidative stress
– DNA damage
▸ Overweight
– Obesity
– Weight loss
▸ Body composition
▸ Glucose tolerance
– Diabetes mellitus (type 1 and 2)
– Metabolic syndrome
▸ Digestion
– Gastrointestinal tract
– Constipation
Table 1 Overall inclusion and exclusion criteria for publication screening
Section Criteria
Include
if:
Language Publication reported in English Yes
Design Randomised or non-randomised food-based trials, or prospective or retrospective cohort or, case–
control, cross-sectional studies
Yes
Case reports, reviews, editorials, letter to the editor, qualitative research No
Population Adults aged 18+ years Yes
Animal studies or studies including <18 years No
Content ▸ Studies examining the relationship between total or specific dietary phytochemical intake from
foods and health outcomes
▸ The intervention advises participants to consume foods rich in phytochemicals:
– Natural whole food, include powder and puree which are food composition complete, such as
blueberries and apple
– Natural whole food juice or drink, such as apple juice
– Complex food, which contains more than one whole food ingredients combination, for example,
fortified bread or cereal bar
▸ Studies examining encapsulated phytochemicals, extract from herbal sources and purified or
modified version of phytochemicals.
▸ Mechanistic studies (ie, bioavailability or mechanistic feeding studies)
Yes
Yes
No
No
Access Full-text article accessible Yes
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▸ Reproductive health
▸ Macular health
▸ Bone health
▸ Mental health
– Cognitive processes
– Cognition
– Mood
– Attention
– Memory
▸ Fatigue
▸ Immunity
The health outcomes are based on preliminary
scoping searches in relation to the topic area being pro-
posed (table 2). Owing to the variability of the health
conditions, the specific outcomes of interest will be tar-
geted based on consistency of reporting within the
studies for a health condition and in turn for a phyto-
chemical subclass. The authors will consider the require-
ment for a three-part review series capturing
cardiovascular disease, cancer and other health condi-
tions where consistency is apparent. This will be deter-
mined following application of the inclusion criteria to
the publications retrieved from the database search. It is
likely that common factors such as height, weight, body
mass index, gender and mortality (as appropriate) can
be applied across all conditions and the principles of
the protocol applicable to a series or single review.
Assessment of reporting biases in individual studies
Systematic error as a result of bias will be considered to
account for selection bias as well as any reporting bias
that may arise within the review.
Two review authors (KK and VXG) will independently
assess the quality for each study using the Cochrane Risk
of Bias Tool50 to address the various forms of bias
related to the extracted studies. This tool will be used to
critically appraise the quality of included studies,
looking at issues of validity of included studies such as
relevance to improve current practice, randomisation,
allocation concealment, blinding, intervention descrip-
tion, validity and reliability of measurements, missing
data, selective reporting. Studies will be scored as low,
unclear or high according to the specified criteria.
Studies will not be excluded on the grounds of their
quality, but the review will report methodological quality
when presenting the results.
Data synthesis
All results will be subject to a rigorous quality assessment
process to ensure data quality is upheld. For all aims,
findings will be presented as a narrative synthesis, as well
as tables and figures. Data synthesis and required statis-
tical analyses as outlined below will be conducted by
YCP and VXG.
Dealing with missing data
Where key data are missing from the included publica-
tions, the review authors will attempt to contact
corresponding authors (or other authors if necessary) of
included studies. If this information is not achievable,
the data will not be imputed and a note will be made
that the study did not provide data for the particular
outcome.
Sensitivity analysis
Although it is unlikely that a meta-analysis will be con-
ducted with the data extracted, sensitivity will be consid-
ered to ensure the decision-making process was robust.
It will demonstrate the influence of the abovementioned
potentially missing data with and without imputations
on the findings of the review. Further to this during the
review process, abstracts that do not contain sufficient
data will be included rather than excluded and progress
to a second review phase of full-text publications.
Studies will only be included if all participants of the
study meet the inclusion criteria. Time points at which
tools in a study are used, for example, dietary assessment
methods will also be extracted for comparability of data
trends.
Subgroup analysis and investigation of heterogeneity
Included publications will be grouped by their phyto-
chemical subclass to determine patterns of reporting in
relation to assessment tools used. The weighted mean
difference of the intervention and control groups for
randomised controlled trial studies will be calculated
and presented with 95% CIs. If mean values are not pro-
vided in the publication, it will be computed using CIs
and the SEM. Heterogeneity of the participant popula-
tion data will be confirmed using a random effects
model. Any abnormal data points will be checked to
ensure incorrect data have not been reported. χ2 and
I2 tests will be conducted to determine the level of het-
erogeneity. The 95% CI of the I2 will be presented and
75% will be identified as considerable heterogeneity.50
High variability of the data is expected.
Meta-bias(es)
Bias related to the systematic error, selective reporting or
publication bias will be considered for all studies
included in the review. This will be determined using
Funnel plots. The scale reversed SE plotted against the
effect estimate with 95% CIs will be considered to address
small sample size bias. This will be indicative of an asym-
metrical plot where the log of the OR to be considered.
Confidence in cumulative evidence
The strength of the body of evidence will be assessed for
each health outcome addressed in the review using the
Grading of Recommendations Assessment, Development
and Evaluation (GRADE) instrument.50 This includes
consideration of the study limitations, indirectness,
inconsistency, imprecision, publication bias within the
studies related to the health outcomes.
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Table 2 Preliminary scoping of publications grouped by phytochemical subclass
Review
Subclass21
Total
publications* Biomarker CVD
Cancer
protection
Cancer
care
Mental
health
Other
disease Food-related Non-food-related
Purified
component
Total health
outcomes
Phenolic acids 138 20 15 15 1 2 8 16 42 9 46
Flavonoids 678 21 104 24 41 14 45 84 283 22 260
Flavanols 26 0 13 1 1 3 1 3 4 0 19
Tannins 172 0 4 0 0 0 5 0 163 0 9
Stilbenes 63 3 0 0 0 0 3 7 49 0 3
Lignanss 133 14 13 1 22 3 23 10 28 6 67
Isoflavones 706 44 28 12 56 3 75 71 209 9 362
Anthocyanins 49 1 4 3 0 0 6 4 25 4 13
Flavanones 11 2 0 0 0 0 0 0 9 0 0
Flavonols 28 0 1 3 1 1 1 7 15 0 7
Flavones 14 0 0 0 0 0 0 1 13 0 0
Allicins 16 0 0 0 0 0 0 5 6 0 5
Capsaicins 609 0 1 1 0 0 13 3 590 1 15
Catechins 143 2 5 3 3 0 11 14 105 0 22
Ellagic acids 12 0 0 0 0 0 0 0 12 0 0
Genisteins 0 0 0 0 0 0 0 0 0 0 0
Lycopenes 116 4 8 8 17 0 10 7 56 0 43
Saponins 72 1 0 0 0 0 0 0 70 1 0
Zeaxanthins 73 3 0 1 1 0 13 5 50 0 15
Polyphenols 244 8 40 13 17 3 26 30 98 8 99
Flavan-3-ols 66 2 13 4 12 9 6 6 6 4 44
Total 3369 125 249 89 172 38 246 273 1833 64 1029
*Where summation of the row exceeds the total number, this is due to inclusion of multiple component in one publication, for example, biomarker and disease outcomes.
CVD, cardiovascular disease.
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Management and review dissemination
The processes of review and synthesis outlined in this
protocol will be undertaken by at least two members of
the review team to ensure quality assurance throughout
the review. Management of the review team will be
upheld by YCP. The entire review team will meet follow-
ing completion of each stage of the review. By compar-
ing the outcomes from experimental and observational
studies, this review will determine whether the overall
conclusions related to the phytochemical subgroups are
the same for the identified health conditions useful to
public health policymakers and health professionals
alike. Review papers to date are often focused on only
one phytochemical class or for meta-analyses only focus
on randomised controlled trials. By considering all of
the evidence for the growing research into phytochem-
icals, the proposed review will provide readers with a
comprehensive update of food-related studies and their
impact on health.
Twitter Follow Yasmine Probst @YasmineProbst
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15. Witkowska AM, Zujko ME, Waśkiewicz A, et al. Comparison of
Various Databases for Estimation of Dietary Polyphenol Intake in the
Population of Polish Adults. Nutrients 2015;7(11):9299–308.
16. Baena Ruiz R, Salinas Hernández P. Cancer chemoprevention by
dietary phytochemicals: epidemiological evidence. Maturitas
2016;94:13–19.
17. Chang SK, Alasalvar C, Shahidi F. Review of dried fruits:
phytochemicals, antioxidant efficacies, and health benefits. J Funct
Foods 2016;21:113–32.
18. Dietz BM, Hajirahimkhan A, Dunlap TL, et al. Botanicals and their
bioactive phytochemicals for women’s health. Pharmacol Rev
2016;68:1026–73.
19. Goya L, Martín MÁ, Sarriá B, et al. Effect of cocoa and its flavonoids
on biomarkers of inflammation: studies of cell culture, animals and
humans. Nutrients 2016;8:212.
20. Rodriguez-Casado A. The health potential of fruits and vegetables
phytochemicals: notable examples. Crit Rev Food Sci Nutr
2016;56:1097–107.
21. Xiao J. Phytochemicals in food and nutrition. Crit Rev Food Sci Nutr
2016;56(Suppl 1):S1–3.
22. Tiwari BK, Brunton NP, Brennan C. Handbook of plant food
phytochemicals: sources, stability and extraction. John Wiley &
Sons, 2013.
23. Ren R, Shi C, Cao J, et al. Neuroprotective effects of a standardized
flavonoid extract of safflower against neurotoxin-induced cellular and
animal models of Parkinson’s disease. Sci Rep 2016;6:22135.
24. Liu XH, Yu RB, Liu R, et al. Association between lutein and
zeaxanthin status and the risk of cataract: a meta-analysis. Nutrients
2014;6:452–65.
25. Tapsell LC. Foods and food components in the Mediterranean diet:
supporting overall effects. BMC Med 2014;12:100.
26. Van Die MD, Bone KM, Williams SG, et al. Soy and soy isoflavones
in prostate cancer: a systematic review and meta-analysis of
randomized controlled trials. BJU Int 2014;113(5B):E119–30.
27. Vuong QV. Epidemiological evidence linking tea consumption
to human health: a review. Crit Rev Food Sci Nutr 2014;54:523–36.
28. Wang ZM, Zhao D, Nie ZL, et al. Flavonol intake and stroke risk: a
meta-analysis of cohort studies. Nutrition 2014;30:518–23.
29. Tresserra-Rimbau A, Rimm EB, Medina-Remón A, et al. Inverse
association between habitual polyphenol intake and incidence of
cardiovascular events in the PREDIMED study. Nutr Metab
Cardiovasc Dis 2014;24:639–47.
30. Mink PJ, Scrafford CG, Barraj LM, et al. Flavonoid intake and
cardiovascular disease mortality: a prospective study in
postmenopausal women. Am J Clin Nutr 2007;85:895–909.
31. Egert S, Rimbach G. Which sources of flavonoids: complex diets or
dietary supplements? Adv Nutr 2011;2:8–14
32. Jacobs DR, Gross MD, Tapsell LC. Food synergy: an operational
concept for understanding nutrition. Am J Clin Nutr 2009;89:
1543S–8S.
33. Neacsu M, McMonagle J, Fletcher RJ, et al. Availability and dose
response of phytophenols from a wheat bran-rich cereal product in
healthy human volunteers. Mol Nutr Food Res 2016.
34. Vitaglione P, Mennella I, Ferracane R, et al. Whole-grain wheat
consumption reduces inflammation in a randomized controlled trial
on overweight and obese subjects with unhealthy dietary and
lifestyle behaviors: role of polyphenols bound to cereal dietary fiber.
Am J Clin Nutr 2015;101:251–61.
35. Forbes-Hernandez TY, Gasparrini M, Afrin S, et al. The healthy
effects of strawberry polyphenols: which strategy behind antioxidant
capacity? Crit Rev Food Sci Nutr 2016;56(Suppl 1):S46–59.
36. Meigs JB, Hu FB, Rifai N, et al. Biomarkers of endothelial dysfunction
and risk of type 2 diabetes mellitus. JAMA 2004;291:1978–86.
37. von Scholten BJ, Reinhard H, Hansen TW, et al. Markers of
inflammation and endothelial dysfunction are associated with
8 Probst YC, et al. BMJ Open 2017;7:e013337. doi:10.1136/bmjopen-2016-013337
Open Access
group.bmj.com on April 12, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
incident cardiovascular disease, all-cause mortality, and progression
of coronary calcification in type 2 diabetic patients with
microalbuminuria. J Diabetes Complications 2016;30:248–55.
38. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein,
interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA
2001;286:327–34.
39. Allin KH, Bojesen SE, Nordestgaard BG. Inflammatory biomarkers
and risk of cancer in 84,000 individuals from the general population.
Int J Cancer 2016;139:1493–500.
40. Wang X, Ouyang YY, Liu J, et al. Flavonoid intake and risk of CVD:
a systematic review and meta-analysis of prospective cohort studies.
B J Nutr 2014;111:1–11.
41. Grimes DA, Schulz KF. An overview of clinical research: the lay of
the land. Lancet 2002;359:57.
42. Chong MF, George TW, Alimbetov D, et al. Impact of the quantity
and flavonoid content of fruits and vegetables on markers of intake
in adults with an increased risk of cardiovascular disease: the
FLAVURS trial. Eur J Nutr 2013;52:361–78.
43. Neuhouser ML. Review: dietary flavonoids and cancer risk:
evidence from human population studies. Nutr Cancer 2004;
50:1–7.
44. Hayes JD, Kelleher MO, Eggleston IM. The cancer chemopreventive
actions of phytochemicals derived from glucosinolates. Eur J Nutr
2008;47:73–88.
45. Wallace TC, Slavin M, Frankenfeld CL. Systematic review of
anthocyanins and markers of cardiovascular disease. Nutrients
2016;8:pii: E32.
46. Li SH, Zhao P, Tian HB, et al. Effect of grape polyphenols on blood
pressure: a meta-analysis of randomized controlled trials. PLoS
ONE 2015;10:e0137665.
47. Zhang GQ, Chen JL, Liu Q, et al. Soy intake is associated with lower
endometrial cancer risk: a systematic review and meta-analysis of
observational studies. Medicine (Baltim) 2015;94:e2281.
48. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement.
Int J Surg 2010;8:336–41.
49. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for
systematic review and meta-analysis protocols (PRISMA-P) 2015:
elaboration and explanation. BMJ 2015;349:g7647.
50. Higgins J, Green S, eds. Cochrane handbook for systematic reviews
of interventions, version 5.1.0. updated March 2011 edn. London:
The Cochrane Collaboration, 2011.
Probst YC, et al. BMJ Open 2017;7:e013337. doi:10.1136/bmjopen-2016-013337 9
Open Access
group.bmj.com on April 12, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
protocol and preliminary scoping
health outcomes: a systematic review 
Dietary phytochemical intake from foods and
Yasmine C Probst, Vivienne X Guan and Katherine Kent
doi: 10.1136/bmjopen-2016-013337
2017 7: BMJ Open 
 http://bmjopen.bmj.com/content/7/2/e013337
Updated information and services can be found at: 
These include:
References
 #BIBLhttp://bmjopen.bmj.com/content/7/2/e013337
This article cites 43 articles, 11 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by-nc/4.0/non-commercial. See: 
provided the original work is properly cited and the use is
non-commercially, and license their derivative works on different terms, 
permits others to distribute, remix, adapt, build upon this work
Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
This is an Open Access article distributed in accordance with the Creative
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (582)Research methods
 (2092)Public health
 (308)Nutrition and metabolism
 (690)Evidence based practice
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on April 12, 2017 - Published by http://bmjopen.bmj.com/Downloaded from 
